by Kyle Becker, BeckerNews:
A cardiologist’s controversial appearance on the BBC has led to formal complaints with the General Medical Council, due to his unsettling revelations about the Covid mRNA vaccines being tied to excess mortality and an increased risk of heart issues.
Dr. Aseem Malhotra in his interview broke the BBC’s iron grip on the public conversation with a bombshell revelation for many who only subscribe to the official narrative on the Covid vaccines. Watch:
TRUTH LIVES on at https://sgtreport.tv/
“Millions more people in England could be prescribed daily cholesterol lowering statin pills to cut their risk of a heart attack or stroke under new advice from the NHS,” the BBC reporter began. “The National Institute for Health and Care Excellence says the cheap price of tablets and the possible health gains mean they should be considered more often in England. High cholesterol leads to around 7% of all deaths.”
“I’m joined now by Dr. Aseem Malhotra,” she continued. “He is a consultant, cardiologist and specializes in statins.”
Yeah, so I have a great respect for NIHCE, but I think in this regard with statins, I think it is misguided,” Dr. Malhotra said. “And the reason I say that is I’ve managed thousands of people with heart disease in my career prescribed statins particularly to high risk people. I just want to, you know, emphasize that people who have had a heart attack or high risk, that’s where we see the greatest benefits of statins. But in this guidance, this basically applies to people who have a less than 10% risk. And if you have a less than 20% risk of having a heart attack or stroke in the next 10 years, one thing that we always tell patients when I describe statins or discuss it with them, is that there is, first of all know what we call mortality benefit. They’re not going to live any longer over a five-year period.”
“And the absolute benefits to them is about 1%, one in a hundred in preventing nonfatal heart attack or stroke,” the doctor continued. “So that informed decision-making needs to be part of the process in discussion with patients and and then help the patient make decision themselves.”
